Introducing Our New SureScreen Diagnostics Factory

As of June 2021, we have opened our new SureScreen Diagnostics Factory, marking another step in the company’s expansion.

The new warehouse comes after the UK government ordered 20 million of our lateral flow tests, not to mention the demand from overseas. This new warehouse and manufacturing site enable SureScreen to provide advanced manufacturing capabilities to help design, build, and deliver innovative, high-quality products at scale.

The new site supports our ability to quickly and reliably design, production, and services to customers throughout Europe and the Rest of the World. We have a
state-of-the-art operating site with fully automated machines enabling the capacity of manufacturing 500 million lateral flow tests per year.

Director David Campbell said: “It is a big investment for us. We see it as a platform for future innovative tests. It will be among the best lateral flow facilities in Europe, and we are expanding in all areas of production and investing in cutting-edge equipment to scale up further. This will mean incredible growth for the company, which comes with challenges, but we are committed to helping governments and companies worldwide to be on top of Covid-19 and its variants.

“We are well-known for Covid-19 tests, but this is a new platform for our other products such as alcohol and drug testing, pregnancy tests, male fertility tests, testing for new infections diseases, HIV and being ready for new health crises. It’s important that we build a platform in the UK to be ready for future healthcare needs, including possible future pandemics, and we believe this facility will help to do just that.”

The new site, which is close to junction 27 of the M1, will be a great asset to the company,  allowing us to continue to expand its high-quality manufacturing and distribution.


Navigating Workplace Drug Testing: Understanding Different Scenarios

Read full article

Office Relocation Announcement

Read full article

We asked, You Answered

Read full article

Drug Retention Times

Read full article